Loading...
Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2‐Year Observational Study
AIMS: We evaluate safety and efficacy of autologous bone marrow‐derived mesenchymal stem cells (MSCs) as a potential treatment for neuromyelitis optica spectrum disorder (NMOSD). METHODS: Fifteen patients with NMOSD were recruited. All patients received a single intravenous infusion of 1.0 × 10(8) a...
Na minha lista:
| Udgivet i: | CNS Neurosci Ther |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2016
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6492909/ https://ncbi.nlm.nih.gov/pubmed/27219819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.12559 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|